3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Neoplasms
3
Recurrence
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Colorectal Neoplasms
2
Carcinoma, Merkel Cell
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pharmacokinetics
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Triple Negative Breast Cancer
1
Interventions
Irinotecan
7
Cyclophosphamide
7
Vincristine
6
Magnetic Resonance Spectroscopy
5
Dactinomycin
5
temsirolimus
4
cixutumumab
4
X-Rays
4
Sirolimus
4
Radiotherapy
4
Phantoms, Imaging
4
Etoposide
4
Doxorubicin
4
Specimen Handling
3
Radiation
3
Peripheral Blood Stem Cell Transplantation
3
Nuclear Medicine Department, Hospital
3
Melphalan
3
Ifosfamide
3
Gemcitabine
3
Filgrastim
3
ulixertinib
2
tipifarnib
2
thymoglobulin
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Rhabdomyosarcoma
×
ALT-803
×
Clear all
No trials found.